Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Parotid Neoplasms 1 Osteosarcoma 1 Hodgkin Disease 1 Cholangiocarcinoma 1 Bone Neoplasms 1

Interventions

Leucovorin 5 Gemcitabine 5 Fluorouracil 5 Cisplatin 5 durvalumab 3 Oxaliplatin 3 Capecitabine 3 pembrolizumab 2 lenvatinib 2 S 1 (combination) 2 Irinotecan 2 Folfox protocol 2 zimberelimab 1 tocilizumab 1 tislelizumab 1 surufatinib 1 regorafenib 1 pemigatinib 1 neratinib 1 fludarabine 1 donafenib 1 dehydroftorafur 1 Surgical Procedures, Operative 1 Radiotherapy 1 Proton Therapy 1 Platinum 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Cholangiocarcinoma × Proton Therapy × Clear all

NCT06434493 2024-08-21

EMPHATIC

The Christie NHS Foundation Trust

Phase NA Not yet recruiting

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡